Overview

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2015-01-27

Target enrollment:

Participant gender:

Summary

This study is designed to examine the long term safety and efficacy of weekly subcutaneously injected albiglutide in combination with a single oral antidiabetic drug for 52 weeks in Japanese subjects with type 2 diabetes mellitus.

Phase:

Phase 3

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

2,4-thiazolidinedione
Biguanides
Glucagon-Like Peptide 1
Glycoside Hydrolase Inhibitors
Hypoglycemic Agents
rGLP-1 protein